LADENBURG THALMANN FINANCIAL SERVICES INC. - TEKLA LIFE SCIENCES INVS ownership

TEKLA LIFE SCIENCES INVS's ticker is HQL and the CUSIP is 87911K100. A total of 52 filers reported holding TEKLA LIFE SCIENCES INVS in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of TEKLA LIFE SCIENCES INVS
ValueSharesWeighting
Q4 2019$862,000
-7.7%
49,430
-20.1%
0.01%
-16.7%
Q3 2019$934,000
+14.2%
61,875
+27.6%
0.01%0.0%
Q2 2019$818,000
-22.2%
48,475
-21.0%
0.01%
-25.0%
Q1 2019$1,051,000
+24.4%
61,357
+9.7%
0.01%0.0%
Q4 2018$845,000
-24.7%
55,911
+1.8%
0.01%
-11.1%
Q3 2018$1,122,000
+2.7%
54,910
-3.4%
0.01%
-10.0%
Q2 2018$1,092,0000.0%56,8340.0%0.01%0.0%
Q1 2018$1,092,000
-4.4%
56,834
-2.3%
0.01%
-9.1%
Q4 2017$1,142,000
-4.6%
58,165
+4.4%
0.01%
-15.4%
Q3 2017$1,197,000
+7.9%
55,717
+4.8%
0.01%0.0%
Q2 2017$1,109,000
+12.2%
53,186
+4.4%
0.01%0.0%
Q1 2017$988,000
+15.6%
50,956
+1.2%
0.01%
+8.3%
Q4 2016$855,000
-5.7%
50,337
+4.0%
0.01%
-14.3%
Q3 2016$907,000
+14.2%
48,406
+4.8%
0.01%
+7.7%
Q2 2016$794,000
-9.9%
46,191
-6.0%
0.01%
-18.8%
Q1 2016$881,000
-25.0%
49,124
-1.2%
0.02%
-27.3%
Q4 2015$1,175,000
+7.2%
49,713
+2.1%
0.02%
-4.3%
Q3 2015$1,096,000
+135.2%
48,708
+194.6%
0.02%
+155.6%
Q2 2015$466,000
+61.8%
16,534
+58.2%
0.01%
+50.0%
Q1 2015$288,000
+21.5%
10,452
+9.8%
0.01%
+20.0%
Q4 2014$237,0009,5200.01%
Other shareholders
TEKLA LIFE SCIENCES INVS shareholders Q4 2015
NameSharesValueWeighting ↓
Logan Stone Capital, LLC 152,742$2,127,6960.84%
NEEDHAM INVESTMENT MANAGEMENT LLC 299,032$4,165,5160.72%
FLAGSHIP HARBOR ADVISORS, LLC 367,119$5,113,9760.48%
1607 Capital Partners, LLC 463,715$6,459,5500.46%
Shaker Financial Services, LLC 66,528$926,7360.40%
180 WEALTH ADVISORS, LLC 111,856$1,558,1480.36%
Cornerstone Advisors, LLC 252,190$3,513,0070.16%
Quantedge Capital Pte Ltd 25,520$355,4940.14%
Elequin Capital, LP 13,356$186,0490.13%
Twelve Points Wealth Management LLC 12,898$179,6690.10%
View complete list of TEKLA LIFE SCIENCES INVS shareholders